Budesonide orodispersible tablet | Search results

Showing 1 to 3 of 3 results for budesonide orodispersible tablet

Sort by

Budesonide orodispersible tablet for inducing remission of eosinophilic oesophagitis (TA708)
Evidence-based recommendations on budesonide as an orodispersible tablet for inducing remission of eosinophilic oesophagitis in adults.
Result type
Technology appraisal guidance
Published
23 June 2021
View recommendations for TA708
Show all sections
Sections for TA708
Budesonide oral suspension for inducing and maintaining remission of eosinophilic oesophagitis in people 2 to 17 years [ID6761]
Awaiting development Reference number: GID-TA12464 Expected publication date: TBC
Result type
Technology appraisal guidance
Status
Awaiting development
Budesonide orodispersible tablet for maintaining remission of eosinophilic oesophagitis in people 18 years and over [ID6486]
Awaiting development Reference number: GID-TA11623 Expected publication date: TBC
Result type
Technology appraisal guidance
Status
Awaiting development